Oral Vancomycin Dosing
For C. difficile-associated diarrhea, the recommended oral vancomycin dose is 125 mg administered 4 times daily for 10 days. 1
Adult Dosing Guidelines
Oral vancomycin is specifically indicated for two conditions:
C. difficile-associated diarrhea
- 125 mg administered orally 4 times daily for 10 days 1
Staphylococcal enterocolitis
- 500 mg to 2 g total daily dose administered orally in 3 or 4 divided doses for 7 to 10 days 1
Pediatric Dosing Guidelines
For patients less than 18 years of age:
- Both C. difficile-associated diarrhea and staphylococcal enterocolitis:
Important Clinical Considerations
Route of Administration
- Oral vancomycin is not systemically absorbed when used for treatment of C. difficile or staphylococcal enterocolitis 1
- Parenteral (IV) vancomycin is not effective for C. difficile-associated diarrhea or staphylococcal enterocolitis 1
- Do not confuse oral dosing with IV dosing regimens, which follow completely different protocols 2
Special Populations
- Patients with inflammatory bowel disorders: May have significant systemic absorption of oral vancomycin 1
- Patients with renal insufficiency: May require monitoring of serum concentrations if there is concern for systemic absorption 1
- Elderly patients (>65 years): Higher risk of nephrotoxicity; renal function should be monitored during and following treatment even with oral therapy 1
Potential Adverse Effects
- Nephrotoxicity can occur following oral vancomycin therapy, particularly in patients >65 years 1
- Risk increases with concomitant aminoglycoside therapy 1
Clinical Pearls
- Oral vancomycin is available as 125 mg and 250 mg capsules 1
- Oral vancomycin is contraindicated in patients with known hypersensitivity to vancomycin 1
- For IV vancomycin (different indication), standard dosing for adults with normal renal function is 15-20 mg/kg/dose every 8-12 hours 2
- Do not use oral vancomycin for systemic infections as it is not absorbed from the gastrointestinal tract 1
Common Pitfalls
- Confusing oral and IV dosing regimens
- Failing to recognize potential for systemic absorption in patients with inflamed intestinal mucosa
- Not monitoring renal function in elderly patients receiving oral vancomycin
- Using oral vancomycin for infections other than C. difficile-associated diarrhea or staphylococcal enterocolitis